We were unable to confirm this increase in LBC risk for PALB2 and CHEK2. CDH1 was non assessable due to absence of a reliable population incidence and the identification of only one case, previously reported [22]. The gene discussed is CHEK2; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.